Nuwellis, Inc.

NUWE Healthcare Medical Devices

Nuwellis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.3 million, down 5.38% from fiscal 2024. In the quarter to June 2026, revenue grew 14.1%, EPS grew 98.8% and free cash flow fell 51.6%, each against the same quarter a year earlier.

0.55 0.00 0.00%
Market cap
$2.0M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
3/9
Altman Z
−76.39
Beneish M
−7.71
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.34 0.15 0.25 0.06
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(0.89) (0.40) (0.70) (0.17)
P/B ratio
0.72 0.46 0.82 0.00
Price to Tangible BV
0.00 0.00 0.86 0.00
EV/Sales
0.45 0.49 0.46 0.06
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(0.39) (0.38) (0.36) (0.05)
EV/FCF
(0.39) (0.37) (0.35) (0.05)
Quick Ratio
1.20 0.85 0.98 1.36
Current Ratio
2.04 1.71 1.56 1.97
Net Debt/EBITDA
1.24 0.42 0.46 1.25
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
1.11 1.03 1.26 0.98
Operating CF/Net income
(6.71) 1.25 0.69 0.66
Capex/Depreciation
(0.48) (0.09) (3.16) (0.24)
Interest Coverage
— — — (0.52)
Research and Development Expense of Revenue
27.20% 36.47% 71.91% 47.84%
Selling, General and Administrative Expense of Revenue
159.63% 132.55% 188.26% 189.18%
Intangible Assets out of Total Assets
0.00 0.00 0.02 0.01
Share Based Compensation of Revenue
0.86% 0.99% 1.04% 1.12%
Graham Net Nets
1.12 1.42 0.70 (5.92)
Graham Number
0.00 0.00 0.00 183.94
Earnings Yield
(3,217.95%) (5,220.16%) (6,091.06%) (4,347.05%)
Free Cash Flow Yield
(335.69%) (911.62%) (532.10%) (2,294.18%)
Revenue per Share
92.76 123.05 40.52 10.87
Operating CF per Share
(131.67) (153.81) (52.48) (17.52)
Capex per Share
(4.10) 0.61 (2.02) (0.05)
Free Cash Flow per Share
(135.77) (153.20) (54.50) (17.57)
Cash per Share
129.46 55.08 35.13 21.64
Shareholders Equity per Share
163.51 133.50 45.01 (11.29)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
163.51 133.50 45.01 (11.29)
Free Cash Flow
(3.24) (3.02) (3.23) (3.18)
Working Capital
3.68 2.15 2.10 3.89
Capital Expenditures
(0.10) 0.01 (0.12) (0.01)
Net Current Asset Value
3.14 1.70 1.54 (3.27)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.04 0.00 0.05 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
1.22 1.61 1.55 1.37
Average Payables
2.25 1.93 2.08 2.95
Average Inventory
2.03 1.81 1.77 1.89
Average Assets
7.36 7.99 6.98 9.16
Average Common Equity
3.54 4.58 3.12 (5.51)

Fold the line items

Columns are period end dates